Ursula von der Leyen, President of the European Commission, assured that the authorizations for the marketing of the already announced vaccines Pfizer and Moderna could arrive in the second half of December.
“If everything goes smoothly, the European Medicines Agency (EMA) tells us that the conditional marketing authorizations for BioNTech and Moderna may be for the second half of December 2020 “explained the German at a press conference.
Likewise, Von der Leyen warned that it would be a “first, first step” and also at the beginning Only a “small number” of doses could be produced: “The big numbers will come later. That’s why we have asked Member States to develop vaccination plans. “
While, Charles Michel, President of the European Council, did not mean the exact time when they will be distributed the first remedies, although he anticipated that it will occur “in the course” of next year: “We work intensively the European Union and the Member States to solve and anticipate the numerous logistical challenges that we are going to face “.
The EMA’s verdict
The authorizations referred to by Von der Leyen are granted by the EMA to medications or vaccines in which the benefits of their use outweigh the risk derived from the fact that there is less data than they are normally required for full authorizations.